The contraceptive devices market size has grown strongly in recent years. It will grow from $13.55 billion in 2025 to $14.4 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to rising awareness of family planning methods, government-supported population control programs, increasing prevalence of unintended pregnancies, expansion of reproductive health services, growing availability of over-the-counter contraceptive products.
The contraceptive devices market size is expected to see strong growth in the next few years. It will grow to $18.31 billion in 2030 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to increasing focus on reproductive autonomy and women’s health, rising demand for long-term and low-maintenance contraception, expansion of digital health and online pharmacy platforms, growing adoption of male contraceptive solutions, increasing public and ngo-led sexual health initiatives. Major trends in the forecast period include rising adoption of long-acting reversible contraceptives, increasing demand for female-controlled contraceptive options, growing acceptance of non-hormonal contraceptive devices, expansion of contraceptive access through online and public channels, increasing focus on dual protection against pregnancy and stis.
The increasing prevalence of sexually transmitted diseases (STDs) is expected to drive growth in the contraceptive device market. STDs are infections primarily spread through sexual contact, affecting various body parts and potentially causing a range of symptoms and health issues. Rising STD rates are linked to factors such as higher sexual activity, inadequate protection, insufficient sexual health education, and difficulties accessing healthcare and testing. Contraceptive devices, particularly condoms, are essential for preventing STDs as they create a barrier that reduces the risk of transmission by preventing direct contact with infectious fluids and lesions. For example, a report by the UK Health Security Agency in July 2024 noted 401,800 new STI diagnoses in England in 2023, a 4.7% increase from the previous year's 383,789 cases. Gonorrhoea diagnoses rose by 7.5%, from 79,268 in 2022 to 85,223 in 2023, while infectious syphilis diagnoses increased by 9.4%, from 8,693 in 2022 to 9,513 in 2023. This growing prevalence of STDs is driving demand for contraceptive devices.
Companies in the contraceptive device market are focusing on developing innovative products, such as contraceptive vaginal rings, to offer convenient, low-maintenance birth control with a once-a-month insertion. A contraceptive vaginal ring is a flexible, hormone-releasing device placed in the vagina, which prevents pregnancy by continuously releasing hormones to inhibit ovulation and thicken cervical mucus. For instance, in October 2023, Xiromed LLC, a US-based pharmaceutical company, introduced the EnilloRing. This contraceptive vaginal ring, developed by Xiromed, combines etonogestrel and ethinyl estradiol and is designed for long-term use, remaining in place for three weeks, followed by a one-week ring-free interval.
In December 2023, Aditxt, a US-based life sciences company, acquired Evofem Biosciences for $100 million. This acquisition includes Evofem’s FDA-approved hormone-free contraceptive gel, Phexxi® (lactic acid, citric acid, and potassium bitartrate). Aditxt aims to use this acquisition to bolster its focus on innovations in autoimmunity, health metrics, life-extending transplant technologies, population health, and women's health. This acquisition enhances Aditxt's collaborative ecosystem and maximizes the potential of its subsidiaries. Evofem Biosciences is a US-based manufacturer of contraceptive devices.
Major companies operating in the contraceptive devices market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Organon Group, Hologic Inc., CooperSurgical Inc., Cipla Inc., Mankind Pharma Ltd., TTK HealthCare Ltd., Merck Sharp & Dohme Corp., Evofem Biosciences Inc., Veru Inc., Agile Therapeutics Inc., Janssen Global Services LLC, HLL Lifecare Ltd., Mayer Laboratories Inc., V-Care Pharma Pvt. Ltd., Vardhaman Lifecare Pvt. Ltd., Actavis Pharma LLC, Pregna International Limited.
North America was the largest region in the contraceptive devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the contraceptive devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the contraceptive devices market by increasing costs for imported medical-grade polymers, latex, hormones, and precision manufacturing components used in condoms, iuds, implants, and vaginal rings. These cost pressures have particularly affected long-acting and implantable contraceptive segments, with asia-pacific and north america experiencing higher exposure due to global supply chain dependence. Higher tariffs have influenced pricing across retail and public distribution channels. However, tariffs have also encouraged local manufacturing, regional sourcing, and public-sector procurement initiatives, supporting long-term supply stability.
The contraceptive devices market research report is one of a series of new reports that provides contraceptive devices market statistics, including contraceptive devices industry global market size, regional shares, competitors with a contraceptive devices market share, detailed contraceptive devices market segments, market trends and opportunities, and any further data you may need to thrive in the contraceptive devices industry. This contraceptive devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Contraceptive devices are medical tools designed to prevent pregnancy. They come in various forms, each with distinct mechanisms and levels of effectiveness. These devices are primarily used to avoid unintended pregnancies and, in some cases, offer protection against sexually transmitted infections (STIs).
The main types of contraceptive devices include male contraceptive devices, female contraceptive devices, female condoms, diaphragms and sponges, vaginal rings, intrauterine devices, sub-dermal implants, and others. Male contraceptive devices, such as condoms and vasectomy procedures, are methods used by men to prevent pregnancy. They include both hormonal and barrier methods. These devices are distributed through various channels, including hospital pharmacies, retail pharmacies, clinics, online platforms, public channels, non-governmental organizations (NGOs), and others.
The contraceptive devices market consists of sales of cervical caps, hormonal injections, emergency contraceptive devices and sterilization products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The contraceptive devices market size is expected to see strong growth in the next few years. It will grow to $18.31 billion in 2030 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to increasing focus on reproductive autonomy and women’s health, rising demand for long-term and low-maintenance contraception, expansion of digital health and online pharmacy platforms, growing adoption of male contraceptive solutions, increasing public and ngo-led sexual health initiatives. Major trends in the forecast period include rising adoption of long-acting reversible contraceptives, increasing demand for female-controlled contraceptive options, growing acceptance of non-hormonal contraceptive devices, expansion of contraceptive access through online and public channels, increasing focus on dual protection against pregnancy and stis.
The increasing prevalence of sexually transmitted diseases (STDs) is expected to drive growth in the contraceptive device market. STDs are infections primarily spread through sexual contact, affecting various body parts and potentially causing a range of symptoms and health issues. Rising STD rates are linked to factors such as higher sexual activity, inadequate protection, insufficient sexual health education, and difficulties accessing healthcare and testing. Contraceptive devices, particularly condoms, are essential for preventing STDs as they create a barrier that reduces the risk of transmission by preventing direct contact with infectious fluids and lesions. For example, a report by the UK Health Security Agency in July 2024 noted 401,800 new STI diagnoses in England in 2023, a 4.7% increase from the previous year's 383,789 cases. Gonorrhoea diagnoses rose by 7.5%, from 79,268 in 2022 to 85,223 in 2023, while infectious syphilis diagnoses increased by 9.4%, from 8,693 in 2022 to 9,513 in 2023. This growing prevalence of STDs is driving demand for contraceptive devices.
Companies in the contraceptive device market are focusing on developing innovative products, such as contraceptive vaginal rings, to offer convenient, low-maintenance birth control with a once-a-month insertion. A contraceptive vaginal ring is a flexible, hormone-releasing device placed in the vagina, which prevents pregnancy by continuously releasing hormones to inhibit ovulation and thicken cervical mucus. For instance, in October 2023, Xiromed LLC, a US-based pharmaceutical company, introduced the EnilloRing. This contraceptive vaginal ring, developed by Xiromed, combines etonogestrel and ethinyl estradiol and is designed for long-term use, remaining in place for three weeks, followed by a one-week ring-free interval.
In December 2023, Aditxt, a US-based life sciences company, acquired Evofem Biosciences for $100 million. This acquisition includes Evofem’s FDA-approved hormone-free contraceptive gel, Phexxi® (lactic acid, citric acid, and potassium bitartrate). Aditxt aims to use this acquisition to bolster its focus on innovations in autoimmunity, health metrics, life-extending transplant technologies, population health, and women's health. This acquisition enhances Aditxt's collaborative ecosystem and maximizes the potential of its subsidiaries. Evofem Biosciences is a US-based manufacturer of contraceptive devices.
Major companies operating in the contraceptive devices market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Organon Group, Hologic Inc., CooperSurgical Inc., Cipla Inc., Mankind Pharma Ltd., TTK HealthCare Ltd., Merck Sharp & Dohme Corp., Evofem Biosciences Inc., Veru Inc., Agile Therapeutics Inc., Janssen Global Services LLC, HLL Lifecare Ltd., Mayer Laboratories Inc., V-Care Pharma Pvt. Ltd., Vardhaman Lifecare Pvt. Ltd., Actavis Pharma LLC, Pregna International Limited.
North America was the largest region in the contraceptive devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the contraceptive devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the contraceptive devices market by increasing costs for imported medical-grade polymers, latex, hormones, and precision manufacturing components used in condoms, iuds, implants, and vaginal rings. These cost pressures have particularly affected long-acting and implantable contraceptive segments, with asia-pacific and north america experiencing higher exposure due to global supply chain dependence. Higher tariffs have influenced pricing across retail and public distribution channels. However, tariffs have also encouraged local manufacturing, regional sourcing, and public-sector procurement initiatives, supporting long-term supply stability.
The contraceptive devices market research report is one of a series of new reports that provides contraceptive devices market statistics, including contraceptive devices industry global market size, regional shares, competitors with a contraceptive devices market share, detailed contraceptive devices market segments, market trends and opportunities, and any further data you may need to thrive in the contraceptive devices industry. This contraceptive devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Contraceptive devices are medical tools designed to prevent pregnancy. They come in various forms, each with distinct mechanisms and levels of effectiveness. These devices are primarily used to avoid unintended pregnancies and, in some cases, offer protection against sexually transmitted infections (STIs).
The main types of contraceptive devices include male contraceptive devices, female contraceptive devices, female condoms, diaphragms and sponges, vaginal rings, intrauterine devices, sub-dermal implants, and others. Male contraceptive devices, such as condoms and vasectomy procedures, are methods used by men to prevent pregnancy. They include both hormonal and barrier methods. These devices are distributed through various channels, including hospital pharmacies, retail pharmacies, clinics, online platforms, public channels, non-governmental organizations (NGOs), and others.
The contraceptive devices market consists of sales of cervical caps, hormonal injections, emergency contraceptive devices and sterilization products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Contraceptive Devices Market Characteristics
3. Contraceptive Devices Market Supply Chain Analysis
4. Global Contraceptive Devices Market Trends and Strategies
5. Contraceptive Devices Market Analysis of End Use Industries
7. Global Contraceptive Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Contraceptive Devices Total Addressable Market (TAM) Analysis for the Market
9. Contraceptive Devices Market Segmentation
10. Contraceptive Devices Market Regional and Country Analysis
11. Asia-Pacific Contraceptive Devices Market
12. China Contraceptive Devices Market
13. India Contraceptive Devices Market
14. Japan Contraceptive Devices Market
15. Australia Contraceptive Devices Market
16. Indonesia Contraceptive Devices Market
17. South Korea Contraceptive Devices Market
18. Taiwan Contraceptive Devices Market
19. South East Asia Contraceptive Devices Market
20. Western Europe Contraceptive Devices Market
21. UK Contraceptive Devices Market
22. Germany Contraceptive Devices Market
23. France Contraceptive Devices Market
24. Italy Contraceptive Devices Market
25. Spain Contraceptive Devices Market
26. Eastern Europe Contraceptive Devices Market
27. Russia Contraceptive Devices Market
28. North America Contraceptive Devices Market
29. USA Contraceptive Devices Market
30. Canada Contraceptive Devices Market
31. South America Contraceptive Devices Market
32. Brazil Contraceptive Devices Market
33. Middle East Contraceptive Devices Market
34. Africa Contraceptive Devices Market
36. Contraceptive Devices Market Competitive Landscape and Company Profiles
37. Contraceptive Devices Market Other Major and Innovative Companies
40. Contraceptive Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Contraceptive Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses contraceptive devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for contraceptive devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The contraceptive devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Male Contraceptive Devices; Female Contraceptive Devices; Female Condoms, Diaphragms And Sponges; Vaginal Rings; Intrauterine Devices; Sub-Dermal Implants; Others Product Types2) By Technology: Hormonal Contraceptives; Barrier Contraceptives
3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Clinics; Online Channels; Public Channel And Non-Governmental Organization (NGO); Other Distribution Channels
Subsegments:
1) By Male Contraceptive Devices: Male Condoms; Vasectomy Devices; Male Contraceptive Injections; Male Contraceptive Pills2) By Female Contraceptive Devices: Female Condoms; Diaphragms And Sponges; Vaginal Rings; Intrauterine Devices (IUDs); Sub-Dermal Implants; Emergency Contraceptive Devices
3) By Female Condoms: Internal Latex Female Condoms; Non-Latex Female Condoms
4) By Diaphragms And Sponges: Silicone Diaphragms; Latex Diaphragms; Contraceptive Sponges
5) By Vaginal Rings: NuvaRing (And Other Hormonal Vaginal Rings); Non-Hormonal Vaginal Rings
6) By Intrauterine Devices (IUDs): Copper IUDs; Hormonal IUDs; Non-Hormonal IUDs
7) By Sub-Dermal Implants: Hormonal Implants; Non-Hormonal Implants
8) By Other Product Types: Contraceptive Patches; Contraceptive Injections; Contraceptive Pills; Contraceptive Gel And Creams
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Bayer AG; Teva Pharmaceutical Industries Ltd.; Mylan N.V.; Organon Group; Hologic Inc.; CooperSurgical Inc.; Cipla Inc.; Mankind Pharma Ltd.; TTK HealthCare Ltd.; Merck Sharp & Dohme Corp.; Evofem Biosciences Inc.; Veru Inc.; Agile Therapeutics Inc.; Janssen Global Services LLC; HLL Lifecare Ltd.; Mayer Laboratories Inc.; V-Care Pharma Pvt. Ltd.; Vardhaman Lifecare Pvt. Ltd.; Actavis Pharma LLC; Pregna International Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Contraceptive Devices market report include:- Pfizer Inc.
- Johnson & Johnson Services Inc.
- Bayer AG
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Organon Group
- Hologic Inc.
- CooperSurgical Inc.
- Cipla Inc.
- Mankind Pharma Ltd.
- TTK HealthCare Ltd.
- Merck Sharp & Dohme Corp.
- Evofem Biosciences Inc.
- Veru Inc.
- Agile Therapeutics Inc.
- Janssen Global Services LLC
- HLL Lifecare Ltd.
- Mayer Laboratories Inc.
- V-Care Pharma Pvt. Ltd.
- Vardhaman Lifecare Pvt. Ltd.
- Actavis Pharma LLC
- Pregna International Limited
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 14.4 Billion |
| Forecasted Market Value ( USD | $ 18.31 Billion |
| Compound Annual Growth Rate | 6.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
